83 related articles for article (PubMed ID: 24846200)
21. Clinical significance of genome-wide minimally deleted regions in oral squamous cell carcinomas.
Chien HT; Liao CT; Huang SF; Chen IH; Liu TY; Jou YS; Wang HM; Hsieh LL
Genes Chromosomes Cancer; 2011 May; 50(5):358-69. PubMed ID: 21344537
[TBL] [Abstract][Full Text] [Related]
22. Potential marker of oral squamous cell carcinoma aggressiveness detected by fluorescence in situ hybridization in fine-needle aspiration biopsies.
Miyamoto R; Uzawa N; Nagaoka S; Nakakuki K; Hirata Y; Amagasa T
Cancer; 2002 Nov; 95(10):2152-9. PubMed ID: 12412169
[TBL] [Abstract][Full Text] [Related]
23. Oral squamous cancer cell exploits hnRNP A1 to regulate cell cycle and proliferation.
Yu C; Guo J; Liu Y; Jia J; Jia R; Fan M
J Cell Physiol; 2015 Sep; 230(9):2252-61. PubMed ID: 25752295
[TBL] [Abstract][Full Text] [Related]
24. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of BST2 is associated with nodal metastasis and poorer prognosis in oral cavity cancer.
Fang KH; Kao HK; Chi LM; Liang Y; Liu SC; Hseuh C; Liao CT; Yen TC; Yu JS; Chang KP
Laryngoscope; 2014 Sep; 124(9):E354-60. PubMed ID: 24706327
[TBL] [Abstract][Full Text] [Related]
26. High prevalence of epigenetic inactivation of the human four and a half LIM domains 1 gene in human oral cancer.
Koike K; Kasamatsu A; Iyoda M; Saito Y; Kouzu Y; Koike H; Sakamoto Y; Ogawara K; Tanzawa H; Uzawa K
Int J Oncol; 2013 Jan; 42(1):141-50. PubMed ID: 23123766
[TBL] [Abstract][Full Text] [Related]
27. Expression of Gα12 predicts progression and prognosis of oral squamous cell carcinomas in Taiwan.
Cheng SJ; Liu YC; Cheng SL; Lee JJ; Chen HM; Chang HH; Kok SH; Kuo MY; Chiang CP
J Oral Pathol Med; 2013 Aug; 42(7):565-9. PubMed ID: 23438080
[TBL] [Abstract][Full Text] [Related]
28. Aberrant expression and localization of decorin in human oral dysplasia and squamous cell carcinoma.
Banerjee AG; Bhattacharyya I; Lydiatt WM; Vishwanatha JK
Cancer Res; 2003 Nov; 63(22):7769-76. PubMed ID: 14633702
[TBL] [Abstract][Full Text] [Related]
29. Defective expression of transforming growth factor beta type II receptor (TGFBR2) in the large cell variant of non-small cell lung carcinoma.
Xu JB; Bao Y; Liu X; Liu Y; Huang S; Wang JC
Lung Cancer; 2007 Oct; 58(1):36-43. PubMed ID: 17566598
[TBL] [Abstract][Full Text] [Related]
30. Expression and prognostic significance of apoptotic genes in oral squamous cell carcinoma.
Lo Muzio L; Sartini D; Santarelli A; Rocchetti R; Morganti S; Pozzi V; Rubini C; Bambini F; Emanuelli M
Mol Carcinog; 2014 Apr; 53(4):264-71. PubMed ID: 23001827
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of p27 expression in carcinoma of the oral cavity and oropharynx.
Venkatesan TK; Kuropkat C; Caldarelli DD; Panje WR; Hutchinson JC; Chen S; Coon JS
Laryngoscope; 1999 Aug; 109(8):1329-33. PubMed ID: 10443844
[TBL] [Abstract][Full Text] [Related]
32. Ki-67 from clinically and histologically "normal" distant mucosa as prognostic marker in early-stage (T1-T2N0) oral squamous cell carcinoma: a prospective study.
Montebugnoli L; Gissi DB; Badiali G; Marchetti C; Cervellati F; Farnedi A; Foschini MP
J Oral Maxillofac Surg; 2011 Oct; 69(10):2579-84. PubMed ID: 21292374
[TBL] [Abstract][Full Text] [Related]
33. Prognostic implication of the loss of TGFBR2 expression in oral carcinoma.
Sivadas VP; Saakshi G; Iype EM; Balan A; Kannan S
Neoplasma; 2015 Apr; ():. PubMed ID: 25866314
[TBL] [Abstract][Full Text] [Related]
34. Mutational inactivation of TGFBR2 in microsatellite unstable colon cancer arises from the cooperation of genomic instability and the clonal outgrowth of transforming growth factor beta resistant cells.
Biswas S; Trobridge P; Romero-Gallo J; Billheimer D; Myeroff LL; Willson JK; Markowitz SD; Grady WM
Genes Chromosomes Cancer; 2008 Feb; 47(2):95-106. PubMed ID: 17985359
[TBL] [Abstract][Full Text] [Related]
35. Calreticulin, an endoplasmic reticulum-resident protein, is highly expressed and essential for cell proliferation and migration in oral squamous cell carcinoma.
Chiang WF; Hwang TZ; Hour TC; Wang LH; Chiu CC; Chen HR; Wu YJ; Wang CC; Wang LF; Chien CY; Chen JH; Hsu CT; Chen JY
Oral Oncol; 2013 Jun; 49(6):534-41. PubMed ID: 23375593
[TBL] [Abstract][Full Text] [Related]
36. Aberrant cell cycle progression contributes to the early-stage accelerated carcinogenesis in transgenic epidermis expressing the dominant negative TGFbetaRII.
Go C; He W; Zhong L; Li P; Huang J; Brinkley BR; Wang XJ
Oncogene; 2000 Jul; 19(32):3623-31. PubMed ID: 10951568
[TBL] [Abstract][Full Text] [Related]
37. Loss of NKX3-1 as a potential marker for an increased risk of occult lymph node metastasis and poor prognosis in oral squamous cell carcinoma.
Miyaguchi K; Uzawa N; Mogushi K; Takahashi K; Michikawa C; Nakata Y; Sumino J; Okada N; Mizushima H; Fukuoka Y; Tanaka H
Int J Oncol; 2012 Jun; 40(6):1907-14. PubMed ID: 22344708
[TBL] [Abstract][Full Text] [Related]
38. DF3 epitope expression on MUC1 mucin is associated with tumor aggressiveness, subsequent lymph node metastasis, and poor prognosis in patients with oral squamous cell carcinoma.
Hamada T; Nomura M; Kamikawa Y; Yamada N; Batra SK; Yonezawa S; Sugihara K
Cancer; 2012 Nov; 118(21):5251-64. PubMed ID: 22434549
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of SRSF3 by antisense oligonucleotides sensitizes oral squamous cell carcinoma and breast cancer cells to paclitaxel treatment.
Sun Y; Yan L; Guo J; Shao J; Jia R
Cancer Chemother Pharmacol; 2019 Nov; 84(5):1133-1143. PubMed ID: 31515668
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of survivin as a prognostic marker in oral squamous cell carcinoma.
Kim YH; Kim SM; Kim YK; Hong SP; Kim MJ; Myoung H
J Oral Pathol Med; 2010 May; 39(5):368-75. PubMed ID: 20050981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
